APPLICATION
ANDA074593
TYPE
ANDA
ORIGINAL APPROVAL
1996-11-04
LATEST ACTION
2012-02-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ETOMIDATEPrescription
ETOMIDATE 2MG/ML · INJECTABLE · INJECTION
Approval history
2012-02-21Labeling · Supplement 12AP
2001-04-03Manufacturing (CMC) · Supplement 2AP
1996-11-04OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.